Novo Nordisk on GLP-1 generics
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email The patent on semaglutide, found…
Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India
India’s market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk’s (NOVOb.CO) patent…
Inside the Legal Battle Between Novo Nordisk and Hims & Hers
When Novo Nordisk filed suit against Hims & Hers in early February, the case immediately drew attention as…
Novo Nordisk opens new front with patent suit over Hims’ Wegovy copies
By Blake Brittain Feb 10 (Reuters) – Novo Nordisk’s U.S. patent lawsuit against Hims & Hers, filed on…